OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Keywords: urinary bladder; overactive; urinary incontinence; onabotulinumtoxinA; injections; intramuscular; botulinum toxins; AE; adverse event; CIC; clean intermittent catheterization; HRQOL; health related QOL; I-QOL; Incontinence QOL; ITT; intent to treat; KHQ;